BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27221212)

  • 1. CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1.
    Dong B; Somani AK; Love PE; Zheng X; Chen X; Zhang J
    Int J Mol Med; 2016 Jul; 38(1):45-56. PubMed ID: 27221212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
    Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
    J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy-terminal region of CD5 is required for c-CBL mediated TCR signaling downmodulation in thymocytes.
    Roa NS; Ordoñez-Rueda D; Chávez-Rios JR; Raman C; García-Zepeda EA; Lozano F; Soldevila G
    Biochem Biophys Res Commun; 2013 Mar; 432(1):52-9. PubMed ID: 23376399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds.
    Carter JD; Neel BG; Lorenz U
    Int Immunol; 1999 Dec; 11(12):1999-2014. PubMed ID: 10590266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine tuning of TCR signaling by CD5.
    Azzam HS; DeJarnette JB; Huang K; Emmons R; Park CS; Sommers CL; El-Khoury D; Shores EW; Love PE
    J Immunol; 2001 May; 166(9):5464-72. PubMed ID: 11313384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase.
    Pani G; Fischer KD; Mlinaric-Rascan I; Siminovitch KA
    J Exp Med; 1996 Sep; 184(3):839-52. PubMed ID: 9064344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
    Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
    J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection.
    Dutz JP; Ong CJ; Marth J; Teh HS
    J Immunol; 1995 Mar; 154(6):2588-99. PubMed ID: 7533178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells.
    Sen G; Bikah G; Venkataraman C; Bondada S
    Eur J Immunol; 1999 Oct; 29(10):3319-28. PubMed ID: 10540344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes.
    Gary-Gouy H; Lang V; Sarun S; Boumsell L; Bismuth G
    J Immunol; 1997 Oct; 159(8):3739-47. PubMed ID: 9378960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection.
    Plas DR; Williams CB; Kersh GJ; White LS; White JM; Paust S; Ulyanova T; Allen PM; Thomas ML
    J Immunol; 1999 May; 162(10):5680-4. PubMed ID: 10229799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells.
    Carmo AM; Castro MA; Arosa FA
    J Immunol; 1999 Oct; 163(8):4238-45. PubMed ID: 10510361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.
    Ordoñez-Rueda D; Lozano F; Sarukhan A; Raman C; Garcia-Zepeda EA; Soldevila G
    Eur J Immunol; 2009 Aug; 39(8):2233-47. PubMed ID: 19609976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cells.
    Sathish JG; Johnson KG; LeRoy FG; Fuller KJ; Hallett MB; Brennan P; Borysiewicz LK; Sims MJ; Matthews RJ
    Eur J Immunol; 2001 Dec; 31(12):3649-58. PubMed ID: 11745385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
    Joliat MJ; Lang PA; Lyons BL; Burzenski L; Lynes MA; Yi T; Sundberg JP; Shultz LD
    J Autoimmun; 2002 Mar; 18(2):105-17. PubMed ID: 11908943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.
    Liu Y; Kruhlak MJ; Hao JJ; Shaw S
    J Leukoc Biol; 2007 Sep; 82(3):742-51. PubMed ID: 17575265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Themis1 enhances T cell receptor signaling during thymocyte development by promoting Vav1 activity and Grb2 stability.
    Zvezdova E; Mikolajczak J; Garreau A; Marcellin M; Rigal L; Lee J; Choi S; Blaize G; Argenty J; Familiades J; Li L; Gonzalez de Peredo A; Burlet-Schiltz O; Love PE; Lesourne R
    Sci Signal; 2016 May; 9(428):ra51. PubMed ID: 27188442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.